GINA BELTRAMI: Open Payments
NPI 1316253750 · EAST ISLIP, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 35 payments from 10 companies in 2025. Trend: 2023 $768 · 2024 $766 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $245 |
| AstraZeneca Pharmaceuticals LP | 2 | $135 |
| Novo Nordisk Inc | 5 | $92 |
| Lilly USA, LLC | 4 | $87 |
| ABBVIE INC. | 4 | $77 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| Amgen Inc. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Exact Sciences Corporation | 1 | $34 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, UBRELVY, GEMTESA, MOUNJARO, OTEZLA, Wegovy, LEQVIO.
Industry payments across NY — which companies pay providers there.
